Skip to product information
DSIP 5mg
  • DSIP 5mg
  • DSIP 5mg
  • DSIP 5mg
  • DSIP 5mg
DSIP 5mg

DSIP 5mg

$25.00

DSIP (Delta Sleep-Inducing Peptide)

 

DSIP is a well-researched, naturally occurring neuropeptide associated with regulating sleep, managing stress, and exhibiting neuroprotective properties.

 

DSIP: The Non-Addictive Neuropeptide for Deep, Restorative Sleep

Delta Sleep-Inducing Peptide (DSIP) is a small, naturally occurring chain of nine amino acids (a nonapeptide) originally isolated from the brain. It is classified as a neuropeptide because it acts as a signaling molecule within the central nervous system.

Key Actions and Reported Effects:

  • Sleep Regulation: DSIP is named for its ability to promote Delta Wave Sleep, which is the slow-wave or deepest, most restorative stage of non-REM sleep essential for physical and mental recovery. It works to enhance sleep quality and architecture without acting as a harsh sedative or disrupting REM sleep.

  • Stress & Hormone Modulation: It has been studied for its ability to help regulate the body's primary stress response system (HPA axis) and may help lower elevated levels of the stress hormone cortisol.

  • Neuroprotection: Research suggests it may possess neuroprotective and antioxidant properties, leading to exploration in neurodegenerative conditions.

  • Withdrawal/Pain Management: Early human trials also indicated a potential role in alleviating symptoms of alcohol and opioid withdrawal and managing certain types of chronic pain.

  • Endocrine Support: It has been linked to the modulation of other hormones, including the promotion of Growth Hormone (GH) release during sleep.

Important Considerations & Safety:

  • Unapproved Status: DSIP is an experimental peptide and is not approved by the FDA for therapeutic use in humans. It is primarily used in scientific research.

  • Dosage & Tolerance: Studies suggest its effects may follow a "bell-shaped curve," meaning very high doses may be less effective or even counterproductive (e.g., causing insomnia). Tolerance may also develop with frequent use.

  • Administration: In research settings and unapproved applications, it is commonly administered via subcutaneous injection before bedtime.

Note: The information provided is based on a body of scientific research, including older human trials and ongoing animal/in vitro studies. DSIP is not an approved drug, and its use is typically limited to a research context.

You may also like